Tag: KDC-MN-260

  • Yohimbine

    Selective alpha-2 adrenergic antagonist

    An indole alkaloid alpha-2 adrenergic antagonist from Pausinystalia johimbe; the canonical pharmacological probe for noradrenergic activation.

    Abstract

    Yohimbine (17-alpha-hydroxy-yohimban-16-alpha-carboxylic acid methyl ester; CAS 146-48-5; molecular formula C21H26N2O3; molecular weight 354.45) is an indole alkaloid isolated from the bark of Pausinystalia johimbe (Rubiaceae) and from Rauwolfia species. The compound is a selective alpha-2 adrenergic antagonist (Ki approximately 1 to 5 nM) with secondary 5-HT1A partial agonism (Ki approximately 100 nM); selectivity for alpha-2 over alpha-1 is approximately 50-fold. Pharmacologically, yohimbine increases central noradrenergic outflow by blocking presynaptic autoinhibition, producing anxiety, increased blood pressure, mydriasis, and tachycardia. Used in clinical research as a provocation test for panic disorder (where vulnerability to alpha-2 antagonism predicts panic susceptibility) and as a positive control in studies of noradrenergic regulation. Folk use as an aphrodisiac for erectile dysfunction has limited supporting evidence. Plasma half-life is approximately 0.6 hours. Used as the canonical alpha-2 antagonist in academic pharmacology.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.